Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.
Location: United States, California, Palo Alto
Employees: 11-50
Total raised: $52M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 04.09.2021 | Y Combinat... | ycombinato... |
| - | Humboldt | humboldtfu... |
| - | Wireframe ... | wireframev... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.06.2022 | - | $52M | - |
Mentions in press and media 1
| Date | Title | Description |
| 27.08.2021 | AstraZeneca promotes oncology exec to CMO; Pfizer replaces retiring chief dealmaker as war chest expands | Cristian Massacesi The biggest bright spot for AstraZeneca over the last few years has been its work in oncology, as CEO Pascal Soriot has helped shepherd blockbusters Imfinzi, Lynparza, and Calquence, among other cancer med... |